TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.
D000970:Antineoplastic Agents; D002066:Busulfan; D002648:Child; D003520:Cyclophosphamide; D003609:Dactinomycin; D006801:Humans; D006918:Hydroxyurea; D007938:Leukemia; D007945:Leukemia, Lymphoid; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D015122:Mercaptopurine; D009369:Neoplasms; D009447:Neuroblastoma; D012509:Sarcoma; D014508:Urea
D000970:Antineoplastic Agents; D003609:Dactinomycin; D003520:Cyclophosphamide; D014508:Urea; D015122:Mercaptopurine; D002066:Busulfan; D006918:Hydroxyurea
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; BUSULFAN; CHILD; CYCLOPHOSPHAMIDE; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; MERCAPTOPURINE; NEUROBLASTOMA; SARCOMA; SARCOMA, RETICULUM CELL; UREA